Stroke pathophysiology: Management challenges and new treatment advances

Journal of Physiology and Biochemistry

Volumn 63, Issue 3, 2007, Pages 261-277

  Jordán, Joaquin ^a,e   Ikuta, I ^b   Garcia Garcia J ^c   Calleja, S ^d   Segura, T ^a,c  

^a Universidad de Castilla La Mancha   (Spain)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Apoptosis; Ischemia; Neurodegeneration; Neuroprotection; Pharmacology

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; ALTEPLASE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; ANISTREPLASE; APTIGANEL; CALCIUM CHANNEL; CILNIDIPINE; CLOMETHIAZOLE; DESMOTEPLASE; DEXTRORPHAN; DIAZEPAM; ELIPRODIL; ETHYLENEGLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID BIS(2 OCTYLOXYETHYL) ESTER; FIBRINOLYTIC AGENT; GAVESTINEL; LOSARTAN; LUBELUZOLE; MAGNESIUM SULFATE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO; RETEPLASE; TENECTEPLASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZONAMPANEL; [1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID; [[3,4 DIHYDRO 7 MORPHOLINO 2,3 DIOXO 6 (TRIFLUOROMETHYL) 1(2H) QUINOXALINYL]METHYL]PHOSPHONIC ACID;

BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; CLINICAL TRIAL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG RECEPTOR BINDING; DRUG TARGETING; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MANAGED CARE; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; SHORT SURVEY; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

ANIMALIA;

EID: 39049123299     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03165789     Document Type: Short Survey

References (86)

1. Adams, H.P., Jr. (2002): Stroke, 33, 856-861.
2. Albers G.W., Bates, V.E., Clark W.M., Bell, R., Verro, P. and Hamilton, S.A. (2000): JAMA, 283, 1145-1150
3. Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L. and Teal, P. (2001): Chest., 119, 300s-320s.
4. Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L. and Teal, P. (2004): Chest., 126, 483s-512s.
5. Alexandrov, A.V., Molina, C.A., Grotta, J.C., et al. (2004): N. Engl. J. Med., 351, 2170-2178.
6. Alvarez-Sabin, J., Huertas, R., Quintana, M., Rubiera, M., Delgado, P., Ribo, M. et al. (2007): Stroke, 38, 1076-1078.
7. Bath, P.M., Iddenden, R., Bath, F.J. and Orgogozo, J.M. (2001): Cochrane Database Syst. Rev. CD002087
8. Britton, M., De F.U. and Helmets, C. (1980): Acta Med. Scand., 207, 253-257.
9. CAST (1997): Lancet, 349, 1641-1649.
10. Choi, D.W. and Rothman, S.M. (1990): Annu. Rev. Neurosci., 13, 171-182.
11. Coull, B.M., Williams, L.S., Goldstein, L.B., Meschia, J.F., Heitzman, D., Chaturvedi, S. et al. (2002): Stroke, 33, 1934-1942.
12. Coull, B.M., Williams, L.S., Goldstein, L.B., Meschia, J.F., Heitzman, D., Chaturvedi, S. et al. (2002): Neurology, 59, 13-22.
13. De Bruijn, S.F. and Stam, J. (1999): Stroke, 30, 484-8.
14. De Georgia, M.A., Krieger, D.W., Abou-Chebl, A., Devlin, T.G., Jauss, M., Davis, S.M. et al. (2004): Neurology, 63, 312-317.
15. Diener, H.C., Hacke, W., Hennerici, M., Radberg, J., Hantson, L. and De Keyser, J (1996): Stroke 27, 76-81.
16. Díez-Tejedor, E. and Fuentes, B. (2004): Cerebrovasc. Dis., 17, 130-137.
17. Dippel, D.W., Van Breda, E.J., Van Gemert, H.M. et al. (2001): Stroke, 32, 1607-1612.
18. Dippel, D.W., Van Breda, E.J., Van Gemert, H.M., Van Der Worp, H.B., Meijer, R.J., Kappelle, L.J. et al. (2001): Stroke, 32, 1607-1612.
19. Einhaupl, K.M., Villringer, A., Meister, W., Mehraein, S., Garner, C., Pellkofer, M. et al. (1991): Lancet, 338, 597-600.
20. Einhaupl, K., Bousser, M.G., De Bruijn, S.F., Ferro, J.M., Martinelli, I., Masuhr, F. et al. (2006): Eur. J. Neurol., 13, 553-9.
21. Erecinska, M., Thoresen, M. and Silver, I.A. (2003): J. Cereb. Blood Flow Metab., 23, 513-530.
22. Fischberg, G.M., Lozano, E., Rajamani, K., Ameriso, S. and Fisher, M.J. (2000): J. Emerg. Med., 19, 339-346.
23. Flaherty, M.I. et al. (2005): Neurology, 64, 386-388.
24. Fujii, K., Weno, B.L., Baumbach, G.L. and Heistad, D.D. (1992): Hypertension, 19, 713-716.
25. Galindo, M.F., Jordan, J., Gonzalez-Garcia, C. and Cena V. (2003) Br. J. Pharmacol., 139, 797-804.
26. Ginsberg, M.D, Hill, M.D., Palesch, Y.Y., Ryckborst, K.J. and Tamariz, D. (2006): Stroke, 37, 2100-6.
27. Ginsberg, M.D. (2003): Stroke, 34, 214-223.
28. Gomez-Lazaro M, Fernandez-Gomez, F.J. and Jordan J. (2004): J. Physiol. Biochem., 60, 287-307.
29. Gomez-Lazaro, M., Galindo, M.F., Melero-Fernandez de Mera, R.M., Fernandez-Gomez, F.J., Concannon, C.G., Segura, M.F., Comella, J.X., Prehn, J.H. and Jordan J. (2007): Mol. Pharmacol., 71, 736-743.
30. Grond, M., Stenzel, C., Schmulling, S. et al. (1998): Stroke, 29, 1544-1549.
31. Hacke, W., Donnan, G., Fieschi, C. et al. (2004): Lancet, 363, 768-774.
32. Hacke W., Kaste, M., Fieschi, C., et al. (1998) Lancet, 352, 1245-1251
33. Hagerdal, M., Harp, J. and Siesjo, B.K. (1975): J. Neurochem., 24, 743-748.
34. Jordan, J., Cena, V. and Prehn, J.H. (2003): J. Physiol. Biochem., 59, 129-141.
35. Jordan, J., Fernandez-Gomez, F.J., Ramos, M., Ikuta, I, Aguirre, N. and Galindo M.F. (2007): Curr. Drug. Deliv., 4, 225-231.
36. Jordan, J., Galindo, M.F, Gonzalez-Garcia, C. and Cena V. (2003) Neuroscience, 122, 707-715.
37. Kaste, M., Hacke, W., Fieschi, C., et al. (1995): Cerebrovasc. Dis., 5, 225.
38. Lampl, Y., Boaz, M., Gilad, R., Lorberboym, M., Dabby, R., Rapoport, A., Anca-Hershkowitz, M. and Sadeh, M. (2007): Neurology, 69, 1404-1410.
39. Larrue, V., Von Kummer, R.R., Muller, A. and Bluhmki, E. (2001): Stroke, 32, 438-441.
40. Lavin, P. (1986): Arch. Intern. Med., 146, 66-68.
41. Lees Kr, Zivin Ja, Ashwood T, et al. (2006): N. Engl. J. Med., 354, 588-600.
42. Linsberg, P.J. and Roine, R.O. (2004): Stroke, 35, 363-364
43. Lipton, S.A. (2007): Curr. Drug. Targets., 8, 621-632.
44. Lisboa, R.C., et al. (2002): Stroke, 33, 2866-2871.
45. Lisk, D.R., Grotta, J.C., Lamki, L.M., Tran, H.D., Taylor, J.W., Molony, D.A. et al. (1993): Arch. Neurol., 50, 855-862.
46. Luo, Y., Yin, W., Signore, A.P., Zhang, F. et al. (2006): J. Neurochem., 97, 435-448.
47. Marti-Fabregas, J., Gomis, M., Arboix, A., Aleu, A., Pagonabarraga, J., Belvis, R. et al. (2004): Stroke, 35, 1117-1121.
48. Mayer, S.A., Kowalski, R.G., Presciutti, M., Ostapkovich, N.D., Mcgann, E., Fitzsimmons, B.F., et al. (2004): Crit. Care Med., 32, 2508-2515.
49. Muir, K.W., Holzapfel, L. and Lees Kr. (2000): Cerebrovasc. Dis., 10, 431-436.
50. Muir, K.W., Lees, K.R., Ford, I. and Davis, S. (2004): Lancet, 363, 439-445.
51. Muir K.W. and Lees, K.R. (2003): Cochrane Database Syst. Rev., Cd001244.
52. Nakashima, K. and Todd, M.M. (1996): Stroke, 27, 913-918.
53. Nombela, F., Blanco, M., Moro, M.A., Rodriguez-Yañez, M., Leira, R., Lizosain, I. et al. (2006): Neurologia, 21, 539.
54. Norris, J.W. (2005): Stroke, 36, 2041-2042.
55. O'connell, J.E. and Gray, C.S. (1996): Drugs Aging, 8, 408-415.
56. Oliveira-Filho, J., Silva, S.C., Trabuco, C.C., Pedreira, B.B., Sousa, E.U. and Bacellar, A. (2003): Neurology, 61, 1047-1051.
57. Palesch, Y.Y., Hill, M.D., Ryckborst, K.J., Tamariz, D. and Ginsberg, M.D. (2006): Stroke, 37, 2107-2114.
58. Pettigrew, L.C., Kasner, S.E., Albers, G.W., et al. (2006): J. Neurol. Sci., 251, 50-56.
59. Powers, W.J. (1993): Neurology, 43, 461-467.
60. Ray, S.K. (2006): Curr. Med. Chem., 13, 3425-3440.
61. Rosenberg, G., Angel, I. and Kozak, A. (2005): Br. J. Clin. Pharmacol., 60, 7-16.
62. Sacco, R.L., Adams, R., Albers, G., Alberts, M.J., Benavente, O., Furie, K. et al. (2006): Circulation, 113, E409-E449.
63. Saver, J.l., Kidwell, C., Eckstein, M. and Starkman, S. (2004): Stroke, 35, E106-E108.
64. Schrader, J., Luders, S., Kulschewskil A., Berger, J., Zidek, W., Treib, J. et al. (2003): Stroke, 34, 1699-1703.
65. Schwartz-Bloom, R.D., Miller, K.A., Evenson, D.A., Crain, B.J. and Nadler, J.V. (2000): Neuroscience, 98, 471-484.
66. Selim, M. and Caplan, L.R. (2004): Curr. Treat Options Cardiovasc. Med., 6, 249-253.
67. Sherman, D.G. (2004): Cerebrovasc. Dis., 17, 138-143.
68. Shin, D.H., Moon, G.J. and Bang, O.Y. (2007): J. Neurol., 254, 870-878.
69. Shuaib, A., Lees, K.R., Lyden, P., Grotta, J., Davalos, A., Davis, S.M., Diener, H.C., Ashwood, T., Wasiewski, W.W. and Emeribe, U: Saint Ii Trial Investigators. (2007): N. Engl. J. Med., 357, 562-571.
70. Smith, W.S., Sung, G., Starkman, S., et al. (2005): Stroke, 36, 1432-1438.
71. Stavrovskaya, I.G., Narayanan, M.V., Zhang, W., Krasnikov, B.F., Heemskerk, J., Young, S.S., Blass, J.P., Brown, A.M., Beal, M.F., Friedlander, R.M. and Kristal, B.S. (2004): J. Exp. Med., 200, 211-222.
72. Takahara, A., Konda, T., Enomoto, A. and Kondo, N. (2004): Biol. Pharm. Bull., 27, 1388-1391.
73. Takata, T., Nabetani, M. and Okada, Y. (1997): Neurosci. Lett., 227, 41-44.
74. Tanne D, Bates V, Verro P, et al. (1999): Neurology, 53, 424-427.
75. Tanne, D., Kasner, S.E., Demchuk, A.M., Koren-Morag, N., Hanson, S., Grond, M. et al. (2002): Circulation, 105, 1679-1685.
76. The International Stroke Trial (Ist). (1997). Lancet, 349, 1569-1581.
77. The National Institute of Neurological Disorders and Stroke. (1995): N. Engl. J. Med., 333, 1581-1587
78. Vlcek, M., Schillinger, M., Lang, W., Lalouschek, W., Bur, A. and Hirschl, M.M. (2003): Ann. Emerg. Med., 42, 619-626.
79. Wahlgren, N., Ahmed, N., Davalos, A., Ford, G.A., Grond, M., Hacke, W., Hennerici, M.G., Kaste M., Kuelkens, S., Larrue, V., Lees, K.R., Roine, R.O. Soinne, L., Toni, D. and Vanhooren, G., Sits-Most Investigators. (2007): Lancet, 369, 275-282. Erratum In: Lancet, 2007, 369, 826.
80. Wahlgren, N.G., Bornhov, S., Sharma, A. et al., For The Class Study Group (1999): J. Stroke Cerebrovasc. Dis., 8, 1-10.
81. Wang, L.M., Yan, Y., Zou, L.J., Jing, N.H. and Xu, Z.Y. (2005): Cell. Res., 15, 387-393.
82. Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T. and Yasuhara H. (1998): Stroke, 29, 12-17
83. Yoon, S.S., Dambrosia, J., Chalela, J. et al. (2004): BMC Med., 23, 2-4.
84. Young, R.S., Zalneraitis, E.L. and Dooling, E.C. (1980): JAMA, 244, 1233-5.
85. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T. and Koistinaho, J. (1998): Proc. Natl. Acad. Sci. U S A, 95, 15769-15774.
86. Zhang, L., Zhang, Z.G., Ding, G.L., Jiang, Q., Liu, X., Meng, H. et al. (2005): Circulation, 112, 3486-3494.